[go: up one dir, main page]

ATE406882T1 - COMPOSITIONS FOR NORMALIZING THE CIRCADIAN RYTHM - Google Patents

COMPOSITIONS FOR NORMALIZING THE CIRCADIAN RYTHM

Info

Publication number
ATE406882T1
ATE406882T1 AT01930144T AT01930144T ATE406882T1 AT E406882 T1 ATE406882 T1 AT E406882T1 AT 01930144 T AT01930144 T AT 01930144T AT 01930144 T AT01930144 T AT 01930144T AT E406882 T1 ATE406882 T1 AT E406882T1
Authority
AT
Austria
Prior art keywords
normalizing
action
circadian rhythm
composition
circadian
Prior art date
Application number
AT01930144T
Other languages
German (de)
Inventor
Yoshinobu Kiso
Yoshiko Ono
Katsuya Nagai
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE406882T1 publication Critical patent/ATE406882T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Electrophonic Musical Instruments (AREA)

Abstract

The present invention provides a circadian rhythm normalizing composition containing astaxanthin and/or its ester as an active ingredient, and a composition having the action of enhancing the circadian rhythm normalizing action of melatonin by protecting melatonin. The composition can be in the form of a drug, a functional food, a food or a beverage. This composition has a circadian rhythm normalizing action, and has the action of preventing or alleviating sleep disorder and various diseases due to disturbance of the circadian rhythm.
AT01930144T 2000-05-16 2001-05-15 COMPOSITIONS FOR NORMALIZING THE CIRCADIAN RYTHM ATE406882T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000143039 2000-05-16

Publications (1)

Publication Number Publication Date
ATE406882T1 true ATE406882T1 (en) 2008-09-15

Family

ID=18649909

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01930144T ATE406882T1 (en) 2000-05-16 2001-05-15 COMPOSITIONS FOR NORMALIZING THE CIRCADIAN RYTHM

Country Status (10)

Country Link
US (1) US7001611B2 (en)
EP (1) EP1283038B1 (en)
AT (1) ATE406882T1 (en)
AU (1) AU780120B2 (en)
CA (1) CA2374958C (en)
DE (1) DE60135647D1 (en)
DK (1) DK1283038T3 (en)
ES (1) ES2312430T3 (en)
PT (1) PT1283038E (en)
WO (1) WO2001087291A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7357947B2 (en) * 2001-09-10 2008-04-15 Biomet, Inc. Bone graft material incorporating demineralized bone matrix and lipids
JP4633048B2 (en) * 2003-03-27 2011-02-16 サントリーホールディングス株式会社 Daily rhythm normalization composition
US20050071207A1 (en) * 2003-09-26 2005-03-31 E2Open Llc Visibility and synchronization in a multi tier supply chain model
KR20060113950A (en) * 2003-12-18 2006-11-03 디에스엠 아이피 어셋츠 비.브이. Uses of Vitamin E
JP4933097B2 (en) 2003-12-19 2012-05-16 株式会社メニコン Treatment and improvement of diabetes and diabetic complications
US8086315B2 (en) 2004-02-12 2011-12-27 Asap Medical, Inc. Cardiac stimulation apparatus and method for the control of hypertension
AR056076A1 (en) * 2005-09-20 2007-09-19 Takeda Pharmaceutical PROFILACTIC OR THERAPEUTIC AGENT FOR SOUND DISORDER
GB0523431D0 (en) * 2005-11-17 2005-12-28 Inst For Akvakulturforskning A Method
US8192773B2 (en) * 2006-12-22 2012-06-05 Kemin Industries, Inc. Carotenoid-based pigmenter
US20080171085A1 (en) * 2007-01-11 2008-07-17 Natrol, Inc. Novel biphasic delivery system for a pharmaceutical or nutraceutical composition and method of administration
JP5356667B2 (en) * 2007-09-28 2013-12-04 ユニチカ株式会社 Composition having normalizing effect on body clock
CA2719059C (en) * 2008-03-27 2016-05-17 Nestec S.A. Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates
EP2123166A1 (en) * 2008-05-15 2009-11-25 Unilever N.V. Edible emulsions with citric acid ester
JP4409617B1 (en) * 2008-12-04 2010-02-03 富士化学工業株式会社 Method for preventing discoloration of carotenoid pigment and container thereof
AU2010293065B2 (en) * 2009-09-11 2016-05-05 Nestec S.A. Compositions and methods for enhancing cognitive and related functions in animals
MX2013006353A (en) * 2010-12-07 2013-08-26 Nestec Sa Methods and compositions useful for promoting sleep in animals.
JPWO2014054651A1 (en) * 2012-10-03 2016-08-25 富士フイルム株式会社 Sleep improving agent, non-REM sleep time increasing agent and sedative
US9008769B2 (en) 2012-12-21 2015-04-14 Backbeat Medical, Inc. Methods and systems for lowering blood pressure through reduction of ventricle filling
US9370662B2 (en) 2013-12-19 2016-06-21 Backbeat Medical, Inc. Methods and systems for controlling blood pressure by controlling atrial pressure
US10342982B2 (en) 2015-09-11 2019-07-09 Backbeat Medical, Inc. Methods and systems for treating cardiac malfunction
CN105193794B (en) * 2015-11-12 2018-03-27 邵小春 One kind sleep spray and preparation method thereof
US10485658B2 (en) 2016-04-22 2019-11-26 Backbeat Medical, Inc. Methods and systems for controlling blood pressure
US10426400B2 (en) 2017-06-23 2019-10-01 International Business Machines Corporation Optimized individual sleep patterns
JP2022188309A (en) * 2019-11-18 2022-12-21 Ｅｎｅｏｓ株式会社 COMPOSITIONS FOR IMPROVING SLEEP QUALITY
CN110882245A (en) * 2019-12-16 2020-03-17 厦门市健康医疗大数据中心(厦门市医药研究所) Composition for improving sleep and application thereof
RU2735833C1 (en) * 2020-03-25 2020-11-09 Федеральное государственное бюджетное учреждение "Северо-Кавказский федеральный научно-клинический центр Федерального медико-биологического агентства" Method of correcting desynchronosis of daily human biorhythms caused by increased physical and psychoemotional loads
CN113144093B (en) * 2021-05-23 2022-07-01 中国人民解放军海军第九七一医院 Traditional Chinese medicine composition for treating circadian rhythm disorder, application and pills thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2619491B2 (en) 1988-08-11 1997-06-11 サントリー株式会社 Astaxanthin-containing composition
JPH05124958A (en) 1991-09-19 1993-05-21 Yukio Date Composition having lipidperoxide-lowering activity
JPH07300421A (en) * 1994-04-28 1995-11-14 Itano Reitou Kk Anti-inflammatory agent
JPH09124470A (en) 1995-10-26 1997-05-13 Suntory Ltd Antistress composition
JPH10155459A (en) * 1996-11-27 1998-06-16 Suntory Ltd Astaxanthin-containing drink

Also Published As

Publication number Publication date
CA2374958A1 (en) 2001-11-22
AU5674001A (en) 2001-11-26
CA2374958C (en) 2010-06-01
DK1283038T3 (en) 2008-12-01
EP1283038A1 (en) 2003-02-12
DE60135647D1 (en) 2008-10-16
PT1283038E (en) 2008-10-23
EP1283038A4 (en) 2003-06-25
US20030091614A1 (en) 2003-05-15
ES2312430T3 (en) 2009-03-01
AU780120B2 (en) 2005-03-03
US7001611B2 (en) 2006-02-21
WO2001087291A1 (en) 2001-11-22
EP1283038B1 (en) 2008-09-03
HK1053269A1 (en) 2003-10-17

Similar Documents

Publication Publication Date Title
ATE406882T1 (en) COMPOSITIONS FOR NORMALIZING THE CIRCADIAN RYTHM
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
IL183401A (en) Use of ornithine and ornithine with at least one phenyl acetate and phenyl butyrate in the manufacture of a medicinal product, products and compositions containing them for use in the prevention or treatment of liver breakdown and encephalopathy of the liver
DE60236541D1 (en) INHIBITORS OF 11-BETA-HYDROXYSTEROIDDEHYDROGENASE TYPE 1
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
ATE447952T1 (en) SYNERGISTIC COMBINATION OF PUMAFENTRINE AND SALMETEROL
EA201070121A1 (en) DOSAGE FORM CONTAINING A SLIP PROTEIN GLP-1-FC
IL192181A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
CY1108794T1 (en) CYCLOEXANE SPIRACYCLICAL DERIVATIVES
ATE113837T1 (en) AGENTS TO COMBAT PAIN, DEPRESSION AND CALM.
EP1767212A4 (en) USE OF THE PLANT OF THE GENUS AMPELOPSIS AND ITS EXTRACTS FOR THE MANUFACTURE OF MEDICAMENTS AND FUNCTIONAL FOOD
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EP1415658A4 (en) REMEDIES
MXPA05013226A (en) Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase.
WO2005062992A3 (en) Substituted melatonin derivatives, process for their preparation, and methods of use
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2004110373A3 (en) Therapeutic vaccine compositions for the treatment of type 1 diabetes
ATE258435T1 (en) PINOLENE ACID AGAINST DIABETES
WO2004010924A3 (en) Pyrroloquinoline quinone drugs as a neuroprotectant and methods of use thereof
EP1161948A3 (en) Pharmaceutical or food composition for treatment of brain edema
IL182297A (en) Use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
ATE293983T1 (en) USE OF N-ACETYL-D-GLUCOSAMINE IN THE PRODUCTION OF A MEDICINAL PRODUCT FOR SUPPRESSING THE SIDE EFFECTS OF RADIATION THERAPY AND CHEMOTHERAPY
ATE363273T1 (en) USE OF ITACONIC ACID TO REGULATE GLYCOLYTIC METABOLISM
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
DE60335810D1 (en) MEDICAL COMPOSITIONS FOR INHIBITING THE EXPRESSION OF ATP CITRATE LYASE AND ITS USE

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties